201 related articles for article (PubMed ID: 31704433)
1. Factors associated with chronic pain and non-medical opioid use among people who inject drugs.
Bicket MC; Park JN; Torrie A; Allen ST; Weir BW; Sherman SG
Addict Behav; 2020 Mar; 102():106172. PubMed ID: 31704433
[TBL] [Abstract][Full Text] [Related]
2. Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore.
Anagnostopoulos A; Abraham AG; Genberg BL; Kirk GD; Mehta SH
Addict Behav; 2018 Jun; 81():39-45. PubMed ID: 29425791
[TBL] [Abstract][Full Text] [Related]
3. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
4. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Geddes L; Iversen J; Wand H; Maher L
Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
[TBL] [Abstract][Full Text] [Related]
5. Correlates of Skin and Soft Tissue Infections in Injection Drug Users in a Syringe-Exchange Program in Malmö, Sweden.
Dahlman D; Håkansson A; Björkman P; Blomé MA; Kral AH
Subst Use Misuse; 2015; 50(12):1529-35. PubMed ID: 26583450
[TBL] [Abstract][Full Text] [Related]
6. Daily opioid and stimulant co-use and nonfatal overdoses in the context of social disadvantage: Findings on marginalized populations.
Jones AA; Schneider KE; Tobin KE; O'Sullivan D; Latkin CA
J Subst Use Addict Treat; 2023 Aug; 151():208986. PubMed ID: 36822268
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.
Rieb LM; DeBeck K; Hayashi K; Wood E; Nosova E; Milloy MJ
Drug Alcohol Depend; 2020 Nov; 216():108242. PubMed ID: 32861135
[TBL] [Abstract][Full Text] [Related]
8. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis.
Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG
Drug Alcohol Depend; 2019 Aug; 201():71-77. PubMed ID: 31195347
[TBL] [Abstract][Full Text] [Related]
9. Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.
Bluthenthal RN; Simpson K; Ceasar RC; Zhao J; Wenger L; Kral AH
Drug Alcohol Depend; 2020 Jun; 211():107932. PubMed ID: 32199668
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD.
Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG
Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195
[TBL] [Abstract][Full Text] [Related]
11. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs.
Reed M; Wagner KD; Tran NK; Brady KA; Shinefeld J; Roth A
Int J Drug Policy; 2019 Nov; 73():32-35. PubMed ID: 31336291
[TBL] [Abstract][Full Text] [Related]
13. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore.
Falade-Nwulia O; Irvin R; Merkow A; Sulkowski M; Niculescu A; Olsen Y; Stoller K; Thomas DL; Latkin C; Mehta SH
J Subst Abuse Treat; 2019 May; 100():45-51. PubMed ID: 30898327
[TBL] [Abstract][Full Text] [Related]
14. Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland.
Buresh M; Genberg BL; Astemborski J; Kirk GD; Mehta SH
Int J Drug Policy; 2019 Dec; 74():41-46. PubMed ID: 31522072
[TBL] [Abstract][Full Text] [Related]
15. Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland.
Buresh M; Gicquelais RE; Astemborski J; Kirk GD; Mehta SH; Genberg BL
PLoS One; 2020; 15(3):e0230127. PubMed ID: 32160244
[TBL] [Abstract][Full Text] [Related]
16. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
17. Physical pain is common and associated with nonmedical prescription opioid use among people who inject drugs.
Dahlman D; Kral AH; Wenger L; Hakansson A; Novak SP
Subst Abuse Treat Prev Policy; 2017 May; 12(1):29. PubMed ID: 28558841
[TBL] [Abstract][Full Text] [Related]
18. Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland.
Cepeda JA; Astemborski J; Kirk GD; Celentano DD; Thomas DL; Mehta SH
PLoS One; 2019; 14(3):e0213357. PubMed ID: 30830944
[TBL] [Abstract][Full Text] [Related]
19. Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
Horyniak D; Agius PA; Degenhardt L; Reddel S; Higgs P; Aitken C; Stoové M; Dietze P
Subst Use Misuse; 2015; 50(13):1650-9. PubMed ID: 26576630
[TBL] [Abstract][Full Text] [Related]
20. Unmet need for medication for opioid use disorder among persons who inject drugs in 23 U.S. cities.
Handanagic S; Broz D; Finlayson T; Kanny D; Wejnert C;
Drug Alcohol Depend; 2024 Apr; 257():111251. PubMed ID: 38457965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
